Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R Clay Bunn

Showing results (21-30 of 25) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 25 results.
Bone|July 28, 2015
SGLT2 inhibitor therapy improves blood glucose but does not prevent diabetic bone disease in diabetic DBA/2J male miceKathryn M Thrailkill, R Clay Bunn, Jeffry S Nyman, et al.
Endocrinology|December 29, 2007
Runt-related transcription factor 2 (RUNX2) and RUNX2-related osteogenic genes are down-regulated throughout osteogenesis in type 1 diabetes mellitusJohn L Fowlkes, R Clay Bunn, Lichu Liu, et al.
Bone|July 27, 2013
Osteo-promoting effects of insulin-like growth factor I (IGF-I) in a mouse model of type 1 diabetesJohn L Fowlkes, Jeffry S Nyman, R Clay Bunn, et al.
JBMR Plus|November 29, 2023
Pharmacologic Inhibition of Myostatin With a Myostatin Antibody Improves the Skeletal Muscle and Bone Phenotype of Male Insulin-Deficient Diabetic MiceR Clay Bunn, Reuben Adatorwovor, Rebecca R Smith, et al.
Bone|December 28, 2010
Increasing duration of type 1 diabetes perturbs the strength-structure relationship and increases brittleness of boneJeffry S Nyman, Jesse L Even, Chan-Hee Jo, et al.
Pageof 3

Showing results (21-30 of 25) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 25 results.
Bone|July 28, 2015
SGLT2 inhibitor therapy improves blood glucose but does not prevent diabetic bone disease in diabetic DBA/2J male miceKathryn M Thrailkill, R Clay Bunn, Jeffry S Nyman, et al.
Endocrinology|December 29, 2007
Runt-related transcription factor 2 (RUNX2) and RUNX2-related osteogenic genes are down-regulated throughout osteogenesis in type 1 diabetes mellitusJohn L Fowlkes, R Clay Bunn, Lichu Liu, et al.
Bone|July 27, 2013
Osteo-promoting effects of insulin-like growth factor I (IGF-I) in a mouse model of type 1 diabetesJohn L Fowlkes, Jeffry S Nyman, R Clay Bunn, et al.
JBMR Plus|November 29, 2023
Pharmacologic Inhibition of Myostatin With a Myostatin Antibody Improves the Skeletal Muscle and Bone Phenotype of Male Insulin-Deficient Diabetic MiceR Clay Bunn, Reuben Adatorwovor, Rebecca R Smith, et al.
Bone|December 28, 2010
Increasing duration of type 1 diabetes perturbs the strength-structure relationship and increases brittleness of boneJeffry S Nyman, Jesse L Even, Chan-Hee Jo, et al.
Pageof 3